Administration time : 510 minutes Method : IV or IM injection Sensation : Mild pressure or warmth during injection Downtime : Nonemost patients resume normal activities immediately Some patients report feeling refreshed shortly after treatment, while skin-related benefits may develop gradually
Low levels mean slower clearance and more inflammation [7]
Lower doses may produce a more noticeable wearing-off effect toward the end of the dosing interval
The clinical trial most often cited is Leyden and colleagues' 2002 randomized 12-week trial of a GHK-Cu facial and eye cream in 71 women with photoaged skin [4]
[DOI] [PubMed] [Google Scholar] 113.Vergote I., Finkler N.J., Hall J.B., Melnyk O., Edwards R.P., Jones M., Keck J.G., Meng L., Brown G.L., Rankin E.M., et al